Identification of proteins adducted by lipid peroxidation products in plasma and modifications of apolipoprotein A1 with a novel biotinylated phospholipid probe

Journal of Proteome Research

Volumn 7, Issue 10, 2008, Pages 4237-4246

  Szapacs, Matthew E ^a   Kim, Hye Young H ^a   Porter, Ned A ^a   Liebler, Daniel C ^a,b  

^a VANDERBILT UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

Affinity probe; Apolipoprotein A1; Lipid electrophile; Protein adduct

Indexed keywords

12 OXO 10(E) DODECENOIC ACID; 7 OXOHEPTANOIC ACID; 8 OXOOCTANOIC ACID; 9 OXONONANOIC ACID; 9,12 DIOXO 10(E) DODECENOIC ACID; APOLIPOPROTEIN A1; CAPSAICIN; CHOLINE; HEPTANOIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN; LINOLEIC ACID; LINOLEOYLGLYCERYLPHOSPHATIDYCHOLINE; NONANOIC ACID; OCTANOIC ACID; PHOSPHOLIPID; PLASMA PROTEIN; UNCLASSIFIED DRUG; BIOTIN; BIOTINYLATED LINOLEOYLGLYCERYLPHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE;

ARTICLE; BIOTINYLATION; BLOOD SAMPLING; CARBOXYLATION; CONTROLLED STUDY; HUMAN; LIPID HYDROLYSIS; LIPID PEROXIDATION; LIQUID CHROMATOGRAPHY; MOLECULAR PROBE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN MODIFICATION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; PROTEIN TARGETING; STOICHIOMETRY; TANDEM MASS SPECTROMETRY; CHEMICAL STRUCTURE; CHEMISTRY; MASS SPECTROMETRY; METABOLISM; PLASMA;

APOLIPOPROTEIN A-I; BIOTIN; BLOOD PROTEINS; CHROMATOGRAPHY, LIQUID; HUMANS; LIPID PEROXIDATION; MASS SPECTROMETRY; MOLECULAR PROBES; MOLECULAR STRUCTURE; PHOSPHATIDYLCHOLINES; PHOSPHOLIPIDS; PLASMA;

EID: 55949122145     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr8001222     Document Type: Article

References (61)

1. Ames, B. N. Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. Science 1983, 221, 1256-1264.
2. Halliwell, B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? [see comments]. Lancet 1994, 344 (8924), 721-724.
3. Berliner, J. A.; Watson, A. D. A role for oxidized phospholipids in atherosclerosis. N. Engl. J. Med. 2005, 353 (1), 9-11.
4. Butterfield, D. A. Amyloid beta-peptide (l-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review. Free Radical Res. 2002, 36 (12), 1307-1313.
5. Perry, G.; Nunomura, A.; Hirai, K.; Zhu, X.; Perez, M.; Avila, J.; Castellani, R. J.; Atwood, C. S.; Aliev, G.; Sayre, L. M; Takeda, A.; Smith, M. A. Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases. Free Radical Biol. Med. 2002, 33 (11), 1475-1479.
6. Beckman, K. B.; Ames, B. N. The free radical theory of aging matures. Physiol. Rev. 1998, 78 (2), 547-581.
7. Ames, B. N. DNA damage from micronutrient deficiencies is likely to be a major cause of cancer. Mutat. Res. 2001, 475 (1-2), 7-20.
8. Marnett, L. J.; Riggins, J. N.; West, J. D. Endogenous generation of reactive oxidants and electrophiles and their reactions with DNA and protein. J. Clin. Invest. 2003, 111 (5), 583-593.
9. Berliner, J. A.; Zimman, A. Future of toxicology-lipidomics, an important emerging area for toxicologists: focus on lipid oxidation products. Chem. Res. Toxicol. 2007, 20 (6), 849-853.
10. Uchida, K. Future of toxicology-lipid peroxidation in the future: from biomarker to etiology. Chem. Res. Toxicol. 2007, 20 (1), 3-5.
11. Kadiiska, M. B.; Gladen, B. C.; Baird, D. D.; Germolec, D.; Graham, L. B.; Parker, C. E.; Nyska, A.; Wachsman, J. T.; Ames, B. N.; Basu, S.; Brot, N.; Fitzgerald, G. A.; Floyd, R. A.; George, M.; Heinecke, J. W.; Hatch, G. E.; Hensley, K.; Lawson, J. A.; Marnett, L. J.; Morrow, J. D.; Murray, D. M.; Plastaras, J.; Roberts, L. J.; Rokach, J.; Shigenaga, M. K.; Sohal, R. S.; Sun, J.; Tice, R. R.; Van Thiel, D. H.; Wellner, D.; Walter, P. B.; Tomer, K. B.; Mason, R. P.; Barrett, J. C. Biomarkers of Oxidative Stress Study II: Are oxidation products of lipids, proteins, and DNA markers of CC1(4) poisoning. Free Radical Biol. Med. 2005, 38 (6), 698-710.
12. Doom, J. A.; Petersen, D. R. Covalent modification of amino acid nucleophiles by the lipid peroxidation products 4-hydroxy-2-nonenal and 4-oxo-2-nonenal. Chem. Res. Toxicol. 2002, 15 (11), 1445-1450.
13. Brame, C. J.; Salomon, R. G.; Morrow, J. D.; Roberts, L. J. Identification of extremely reactive gamma-ketoaldehydes (isole-vuglandins) as products of the isoprostane pathway and characterization of their lysyl protein adducts. J. Biol. Chem. 1999, 274 (19), 13139-13146.
14. Brame, C. J.; Boutaud, O.; Davies, S. S.; Yang, T.; Oates, J. A.; Roden, D.; Roberts, L. J. Modification of proteins by isoketal-containing oxidized phospholipids. J. Biol. Chem. 2004, 279 (14), 13447-13451.
15. Lin, D.; Lee, H. G.; Liu, Q.; Perry, G.; Smith, M. A.; Sayre, L. M. 4-Oxo-2-nonenal is both more neurotoxic and more protein reactive than 4-hydroxy-2-nonenaI. Chem. Res. Toxicol. 2005, 18 (8), 1219-1231.
16. Zhu, X.; Sayre, L. M. Long-lived 4-oxo-2-enal-derived apparent lysine michael adducts are actually the isomeric 4-ketoamides. Chem. Res. Toxicol. 2007, 20 (2), 165-170.
17. Williams, M. V.; Wishnok, J. S.; Tannenbaum, S. R. Covalent adducts arising from the decomposition products of lipid hydroperoxides in the presence of cytochrome c. Chem. Res. Toxicol. 2007, 20 (5), 767-775.
18. Liu, Z.; Minkler, P. E.; Sayre, L. M. Mass spectroscopic characterization of protein modification by 4-hydroxy-2-(E)-nonenal and 4-oxo-2-(E)-nonenal. Chem. Res. Toxicol. 2003, 16 (7), 901-911.
19. Bolgar, M. S.; Yang, C. Y.; Gaskell, S. J. First direct evidence for lipid/protein conjugation in oxidized human low density lipoprotein. J. Biol. Chem. 1996, 271 (45), 27999-28001.
20. Carbone, D. L.; Doom, J. A.; Kiebler, Z.; Sampey, B. P.; Petersen, D. R. Inhibition of Hsp72-mediated protein refolding by 4-hydroxy-2-nonenal. Chem. Res. Toxicol. 2004, 17 (11), 1459-1467.
21. Carbone, D. L.; Doom, J. A.; Kiebler, Z.; Petersen, D. R. Cysteine modification by lipid peroxidation products inhibits protein disulfide isomerase. Chem. Res. Toxicol. 2005, 18 (8), 1324-1331.
22. Carbone, D. L.; Doom, J. A.; Kiebler, Z.; Ickes, B. R.; Petersen, D. R. Modification of heat shock protein 90 by 4-hydroxynonenal in a rat model of chronic alcoholic liver disease. J. Pharmacol. Exp. Ther. 2005, 315 (1), 8-15.
23. Alderton, A. L.; Faustman, C; Liebler, D. C; Hill, D. W. Induction of redox instability of bovine myoglobin by adduction with 4-hydroxy-2-nonenal. Biochemistry 2003, 42, 4398-4405.
24. Sampey, B. P.; Carbone, D. L.; Doom, J. A.; Drechsel, D. A.; Petersen, D. R. 4-Hydroxy-2-nonenal adduction of extracellular signal-regulated kinase (Erk) and the inhibition of hepatocyte Erk-Est-like protein-l-activating protein-1 signal transduction. Mol. Pharmacol. 2007, 71 (3), 871-883.
25. Suman, S. P.; Faustman, C; Stamer, S. L.; Liebler, D. C. Proteomics of lipid oxidation-induced oxidation of porcine and bovine oxy-myoglobins. Proteomics 2007, 7 (4), 628-640.
26. Szapacs, M. E.; Riggins, J. N.; Zimmerman, L. J.; Liebler, D. C. Covalent adduction of human serum albumin by 4-hydroxy-2-nonenal: kinetic analysis of competing alkylation reactions. Biochemistry 2006, 45 (35), 10521-10528.
27. Watson, A. D.; Subbanagounder, G.; Welsbie, D. S.; Faull, K. F.; Navab, M.; Jung, M. E.; Fogelman, A. M.; Berliner, J. A. Structural identification of a novel pro-inflammatory epoxyisoprostane phospholipid in mildly oxidized low density lipoprotein. J. Biol. Chem. 1999, 274 (35), 24787-24798.
28. Subbanagounder, G.; Leitinger, N.; Schwenke, D. C; Wong, J. W.; Lee, H.; Rizza, C; Watson, A. D.; Faull, K. F.; Fogelman, A. M.; Berliner, J. A. Determinants of bioactivity of oxidized phospholipids. Specific oxidized fatty acyl groups at the sn-2 position. Arterioscler., Thromb., Vase. Biol. 2000, 20 (10), 2248-2254.
29. Subbanagounder, G.; Wong, J. W.; Lee, H.; Faull, K. F.; Miller, E.; Witztum, J. L.; Berliner, J. A. Epoxyisoprostane and epoxycyclo-pentenone phospholipids regulate monocyte chemotactic protein-1 and interleukin-8 synthesis. Formation of these oxidized phospholipids in response to interleukin-1beta. J. Biol. Chem. 2002, 277 (9), 7271-7281.
30. Podrez, E. A.; Poliakov, E.; Shen, Z.; Zhang, R.; Deng, Y.; Sun, M.; Finton, P. J.; Shan, L.; Febbraio, M.; Hajjar, D. P.; Silverstein, R. L.; Hoff, H. F.; Salomon, R. G.; Hazen, S. L. A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions. J. Biol. Chem. 2002, 277(41), 38517-38523.
31. Podrez, E. A.; Poliakov, E.; Shen, Z.; Zhang, R.; Deng, Y.; Sun, M.; Finton, P. J.; Shan, L.; Gugiu, B.; Fox, P. L.; Hoff, H. F.; Salomon, R. G.; Hazen, S. L. Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36. J. Biol. Chem. 2002, 277 (41), 38503-38516.
32. Podrez, E. A.; Byzova, T. V.; Febbraio, M.; Salomon, R. G.; Ma, Y; Valiyaveettil, M.; Poliakov, E.; Sun, M.; Finton, P. J.; Curtis, B. R.; Chen, J.; Zhang, R.; Silverstein, R. L.; Hazen, S. L. Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic pheno-type. Nat. Med. 2007, 13 (9), 1086-1095.
33. Porter, N. A.; Caldwell, S. E.; Mills, K. A. Mechanisms of free radical oxidation of unsaturated lipids. Lipids 1995, 30 (4), 277-290.
34. Roberts, L. J.; Salomon, R. G.; Morrow, J. D.; Brame, C. J. New developments in the isoprostane pathway: identification of novel highly reactive gamma-ketoaldehydes (isolevuglandins) and characterization of their protein adducts. FASEB J. 1999, 13 (10), 1157-1168.
35. Lee, S. H.; Oe, T.; Blair, I. A. Vitamin C-induced decomposition of lipid hydroperoxides to endogenous genotoxins. Science 2001, 292 (5524), 2083-2086.
36. Tallman, K. A.; Kim, H. Y; Ji, J. X.; Szapacs, M. E.; Yin, H.; Mcintosh, T. J.; Liebler, D. C; Porter, N. A. Phospholipid-protein adducts of lipid peroxidation: synthesis and study of new biotinylated phosphatidylcholines. Chem. Res. Toxicol. 2007, 20 (2), 227-234.
37. Schumaker, V. N.; Puppione, D. L. Sequential flotation ultracen-trifugation. Methods Enzymol. 1986, 128, 155-170.
38. England, P. M.; Lester, H. A.; Dougherty, D. A. Mapping disulfide connectivity using backbone ester hydrolysis. Biochemistry 1999, 38 (43), 14409-14415.
39. Spahr, C. S.; Davis, M. T.; McGinley, M. D.; Robinson, J. H.; Bures, E. J.; Beierle, J.; Mort, J.; Courchesne, P. L.; Chen, K.; Wahl, R. C; Yu, W.; Luethy, R.; Patterson, S. D. Towards defining the urinary proteome using liquid chromatography-tandem mass spectrom-etry. I. Profiling an unfractionated tryptic digest. Proteomics 2001, 1 (1), 93-107.
40. Eng, J. K.; McCormack, A. L.; Yates, J. R. An Approach to Correlate Tandem Mass-Spectral Data of Peptides with Amino-Acid-Sequences in A Protein Database. J. Am. Soc. Mass Spectrom. 1994, 5 (11), 976-989.
41. Ham, A. J.; Caprioli, R. M.; Gross, M. L., Proteolytic Digestion Protocols. In The Encyclopedia of Mass Spectrometry, Volume 2 Biological Applications Part A: Peptides and Proteins. Elsevier Ltd.: Kidlington, Oxford, U.K., 2005; pp 10-17.
42. Hansen, B. T.; Davey, S. W.; Ham, A. J.; Liebler, D. C. P-Mod: an algorithm and software to map modifications to peptide sequences using tandem MS data. J. Proteome Res. 2005, 4 (2), 358-368.
43. Schneider, C; Tallman, K. A.; Porter, N. A.; Brash, A. R. Two distinct pathways of formation of 4-hydroxynonenal. Mechanisms of nonenzymatic transformation of the 9-and 13-hydroperoxides of linoleic acid to 4-hydroxyalkenals. J. Biol. Chem. 2001, 276 (24), 20831-20838.
44. Wu, Z.; Wagner, M. A.; Zheng, L.; Parks, J. S.; Shy, J. M., III; Smith, J. D.; Gogonea, V.; Hazen, S. L. The refined structure of nascent HDL reveals a key functional domain for particle maturation and dysfunction. Nat. Struct. Mol. Biol. 2007, 14 (9), 861-868.
45. Stahl, D. C; Swiderek, K. M.; Davis, M. T.; Lee, T. D. Data-controlled automation of liquid chromatography/tandem mass spectrometry analysis of peptide mixtures. J. Am. Soc. Mass Spectrom. 1995, 7, 532-540.
46. Barter, P. J.; Rye, K. A. Relationship between the concentration and antiatherogenic activity of high-density lipoproteins. Curr. Opin. Lipidol. 2006, 17 (4), 399-403.
47. Kontush, A.; Chapman, M. J. Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipi-demia, inflammation, and atherosclerosis. Pharmacol. Rev. 2006, 58 (3), 342-374.
48. Assmann, G.; Gotto, A. M., Jr. HDL cholesterol and protective factors in atherosclerosis. Circulation 2004, 109 (23 Suppl. 1), III8-14.
49. Zheng, L.; Nukuna, B.; Brennan, M. L.; Sun, M.; Goormastic, M.; Settle, M.; Schmitt, D.; Fu, X.; Thomson, L.; Fox, P. L.; Ischirop-oulos, H.; Smith, J. D.; Kinter, M.; Hazen, S. L. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J. Clin. Invest. 2004, 114 (4), 529-541.
50. Nicholls, S. J.; Hazen, S. L. Myeloperoxidase and cardiovascular disease. Arterioscler., Thromb., Vase. Biol. 2005, 25 (6), 1102-1111.
51. Nicholls, S. J.; Zheng, L.; Hazen, S. L. Formation of dysfunctional high-density lipoprotein by myeloperoxidase. Trends. Cardiovasc. Med. 2005, 15 (6), 212-219.
52. Peng, D. Q.; Wu, Z.; Brubaker, G.; Zheng, L.; Settle, M.; Gross, E.; Kinter, M.; Hazen, S. L.; Smith, J. D. Tyrosine modification is not required for myeloperoxidase-induced loss of apolipoprotein A-I functional activities. J. Biol. Chem. 2005, 280 (40), 33775-33784.
53. Shao, B.; Bergt, C; Fu, X.; Green, P.; Voss, J. C; Oda, M. N.; Oram, J. F.; Heinecke, J. W. Tyrosine 192 in apolipoprotein A-I is the major site of nitration and chlorination by myeloperoxidase, but only chlorination markedly impairs ABCA1-dependent cholesterol transport. J. Biol. Chem. 2005, 280 (7), 5983-5993.
54. Shao, B.; Oda, M. N.; Bergt, C; Fu, X.; Green, P. S.; Brot, N.; Oram, J. F.; Heinecke, J. W. Myeloperoxidase impairs ABCA1-dependent cholesterol efflux through methionine oxidation and site-specific tyrosine chlorination of apolipoprotein A-I. J. Biol. Chem. 2006, 281 (14), 9001-9004.
55. Shao, B.; Fu, X.; McDonald, T. O.; Green, P. S.; Uchida, K.; O'Brien, K. D.; Oram, J. F.; Heinecke, J. W. Acrolein impairs ATP binding cassette transporter A1-dependent cholesterol export from cells through site-specific modification of apolipoprotein A-I. J. Biol. Chem. 2005, 280 (43), 36386-36396.
56. Shao, B.; O'Brien, K, D.; McDonald, T. O.; Fu, X.; Oram, J. F.; Uchida, K.; Heinecke, J. W. Acrolein modifies apolipoprotein A-I in the human artery wall. Ann. N.Y. Acad. Sci. 2005, 1043, 396-403.
57. Friedman, P.; Horkko, S.; Steinberg, D.; Witztum, J. L.; Dennis, E. A. Correlation of antiphospholipid antibody recognition with the structure of synthetic oxidized phospholipids. Importance of Schiff base formation and aldol concentration. J. Biol. Chem. 2002, 277 (9), 7010-7020.
58. Chang, M. K.; Bergmark, C; Laurila, A.; Horkko, S.; Han, K. H.; Friedman, P.; Dennis, E. A.; Witztum, J. L. Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition. Proc. Natl. Acad. Sci. U.S.A. 1999, 96 (11), 6353-6358.
59. Chang, M. K.; Binder, C. J.; Torzewski, M.; Witztum, J. L. C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids. Proc. Natl. Acad. Sci. U.S.A. 2002, 99 (20), 13043-13048.
60. Watson, A. D.; Leitinger, N.; Navab, M.; Faull, K. F.; Horkko, S.; Witztum, J. L.; Palinski, W.; Schwenke, D.; Salomon, R. G.; Sha, W.; Subbanagounder, G.; Fogelman, A. M.; Berliner, J. A. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J. Biol. Chem. 1997, 272 (21), 13597-13607.
61. Zheng, L.; Settle, M; Brubaker, G.; Schmitt, D.; Hazen, S. L.; Smith, J. D.; Kinter, M. Localization of nitration and chlorination sites on apolipoprotein A-I catalyzed by myeloperoxidase in human atheroma and associated oxidative impairment in ABCA1-dependent cholesterol efflux from macrophages. J. Biol. Chem. 2005, 280 (1), 38-47.